Compound (P)-14

atropisomeric PI3K beta-selective inhibitor

off-target tox. in higher species, discontinued

from rational design of known starting point

J. Med. Chem., Apr. 15, 2020

Gilead Sciences, Seattle, WA + Foster

“Compound (P)-14″ is a PI3K beta-isoform selective lipid kinase inhibitor. While the compound is potent and has excellent oral PK in higher species, significant irreversible toxicity was observed in a…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.